212 BuseJBHenryRRHanJKimDDFinemanMSBaronADet al
When it comes to Retatrutide, the TRIUMPH Phase 3 program is evaluating it for chronic weight management, obstructive sleep apnea, knee osteoarthritis, and cardiovascular outcomes, with data continuing to emerge
In addition, a recent study has identified a novel variant (rs143276236) in the gene ARFGEF3 in the discovery cohort with a potential to reduce HbA1c in individuals with metformin monotherapy in African-Americans, although this find was not significant in the validation cohort (Wu et al., 2023)
Kaufman KD, Olsen EA, Whiting D, et al
Many report that adding BPC-157 during dose escalation phases helps them push through the adjustment period with less discomfort
They believe lifestyle changes must happen in order to maintain long-term progress, which makes them different than most dieting programs